Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
Clinical trial NCT01716975 · COMPLETED
Trial details
- NCT number
- NCT01716975
- Sponsor
- FORUM Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-02-01
- Enrollment
- 767
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.